195 related articles for article (PubMed ID: 7237712)
1. Acute effects of oral pirbuterol on myocardial oxygen metabolism and systemic hemodynamics in chronic congestive heart failure.
Rude RE; Turi Z; Brown EJ; Lorell BH; Colucci WS; Mudge GH; Taylor CR; Grossman W
Circulation; 1981 Jul; 64(1):139-45. PubMed ID: 7237712
[TBL] [Abstract][Full Text] [Related]
2. Effects of amrinone on myocardial energy metabolism and hemodynamics in patients with severe congestive heart failure due to coronary artery disease.
Benotti JR; Grossman W; Braunwald E; Carabello BA
Circulation; 1980 Jul; 62(1):28-34. PubMed ID: 7379283
[TBL] [Abstract][Full Text] [Related]
3. Hemodynamic effects of oral pirbuterol in chronic severe congestive heart failure.
Awan NA; Evenson MK; Needham KE; Evans TO; Hermanovich J; Taylor CR; Amsterdam E; Mason DT
Circulation; 1981 Jan; 63(1):96-101. PubMed ID: 7438412
[TBL] [Abstract][Full Text] [Related]
4. Pirbuterol: a new oral sympathomimetic amine for the treatment of congestive heart failure.
Sharma B; Hoback J; Francis GS; Hodges M; Asinger RW; Cohn JN; Taylor CR
Am Heart J; 1981 Sep; 102(3 Pt 2):533-41. PubMed ID: 6115572
[TBL] [Abstract][Full Text] [Related]
5. Hemodynamic and metabolic effects of isosorbide dinitrate in chronic congestive heart failure.
Gray R; Chatterjee K; Vyden JK; Ganz W; Forrester JS; Swan HJ
Am Heart J; 1975 Sep; 90(3):346-52. PubMed ID: 1163426
[TBL] [Abstract][Full Text] [Related]
6. Potential value of oral beta 2-adrenoceptor agonists in congestive heart failure: a haemodynamic and metabolic study.
Timmis AD; Bergman G; Walker L; Monaghan MJ; Jewitt DE
Int J Cardiol; 1984 Mar; 5(3):327-38. PubMed ID: 6706438
[TBL] [Abstract][Full Text] [Related]
7. Flosequinan, a new vasodilator: systemic and coronary hemodynamics and neuroendocrine effects in congestive heart failure.
Cavero PG; De Marco T; Kwasman M; Lau D; Liu M; Chatterjee K
J Am Coll Cardiol; 1992 Dec; 20(7):1542-8. PubMed ID: 1452928
[TBL] [Abstract][Full Text] [Related]
8. The acute hemodynamic response to pirbuterol at rest and exercise in patients with heart failure with observations on long-term response.
Uretsky BF; Seecof RM; Reddy PS
Can J Cardiol; 1986; 2(2):80-5. PubMed ID: 3085906
[TBL] [Abstract][Full Text] [Related]
9. [Does chronic oral treatment with beta-receptor blockers have an effect on positive inotropic therapy of coronary patients with adrenaline after extracorporeal circulation?].
Günnicker M; Brinkmann M; Freund U; Piotrowski J; Schieffer M; Velser U
Herz; 1995 Dec; 20(6):399-411. PubMed ID: 8582699
[TBL] [Abstract][Full Text] [Related]
10. Myocardial and systemic effects of nitroglycerin, given awake and during anaesthesia in coronary patients.
Moffitt EA; Sethna DH; Gray RJ; Raymond MJ; Bussell JA; Matloff JM
Can Anaesth Soc J; 1983 Jul; 30(4):352-9. PubMed ID: 6409387
[TBL] [Abstract][Full Text] [Related]
11. Effects of atrial natriuretic factor on coronary hemodynamics and myocardial energetics in patients with heart failure.
Herrmann HC; Palacios IF; Dec GW; Scheer JM; Fifer MA
Am Heart J; 1988 Jun; 115(6):1232-8. PubMed ID: 2967626
[TBL] [Abstract][Full Text] [Related]
12. RO13-6438, a new inotrope-vasodilator: systemic and coronary hemodynamic effects in congestive heart failure.
Daly PA; Chatterjee K; Viquerat CE; Parmley WW; Curran D; Scheinbaum M; Anderson S
Am J Cardiol; 1985 Jun; 55(13 Pt 1):1539-44. PubMed ID: 4003296
[TBL] [Abstract][Full Text] [Related]
13. Effects of hydralazine on coronary blood flow and myocardial energetics in congestive heart failure.
Magorien RD; Brown GP; Unverferth DV; Nelson S; Boudoulas H; Bambach D; Leier CV
Circulation; 1982 Mar; 65(3):528-33. PubMed ID: 7055874
[TBL] [Abstract][Full Text] [Related]
14. A new beta-2 adrenoceptor agonist (pirbuterol) in the treatment of ischaemic heart failure.
Nelson GI; Silke B; Barker MC; Saxton CA; Taylor SH
Eur Heart J; 1982 Jun; 3(3):238-45. PubMed ID: 6125392
[No Abstract] [Full Text] [Related]
15. Systemic and coronary hemodynamic and neurohumoral effects of levodopa in chronic congestive heart failure.
De Marco T; Daly PA; Chatterjee K
Am J Cardiol; 1988 Dec; 62(17):1228-33. PubMed ID: 2904216
[TBL] [Abstract][Full Text] [Related]
16. Coronary hemodynamic effects of angiotensin inhibition by captopril and teprotide in patients with congestive heart failure.
Halperin JL; Faxon DP; Creager MA; Bass TA; Melidossian CD; Gavras H; Ryan TJ
Am J Cardiol; 1982 Nov; 50(5):967-72. PubMed ID: 6182786
[TBL] [Abstract][Full Text] [Related]
17. Dopexamine hydrochloride in chronic congestive heart failure with improved cardiac performance without increased metabolic cost.
De Marco T; Kwasman M; Lau D; Chatterjee K
Am J Cardiol; 1988 Aug; 62(5):57C-62C. PubMed ID: 3407596
[TBL] [Abstract][Full Text] [Related]
18. Effect of enoximone alone and in combination with metoprolol on myocardial function and energetics in severe congestive heart failure: improvement in hemodynamic and metabolic profile.
Galie N; Branzi A; Magnani G; Melandri G; Caldarera I; Rapezzi C; Grattoni C; Magnani B
Cardiovasc Drugs Ther; 1993 Jun; 7(3):337-47. PubMed ID: 8364004
[TBL] [Abstract][Full Text] [Related]
19. Effects of ouabain on myocardial oxygen supply and demand in patients with chronic coronary artery disease. A hemodynamic, volumetric, and metabolic study in patients without heart failure.
DeMots H; Rahimtoola SH; Kremkau EL; Bennett W; Mahler D
J Clin Invest; 1976 Aug; 58(2):312-9. PubMed ID: 783197
[TBL] [Abstract][Full Text] [Related]
20. Effects of milrinone on coronary hemodynamics and myocardial energetics in patients with congestive heart failure.
Monrad ES; Baim DS; Smith HS; Lanoue A; Brauwald E; Grossman W
Circulation; 1985 May; 71(5):972-9. PubMed ID: 3986984
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]